发明名称 METHODS FOR CONTROLLING CELL FATE AND CONSEQUENCES FOR DISEASE
摘要 Provided herein are methods for performing cellular reprogramming that include treatment of somatic cells with an inhibitor of CAF-1, Sumo2, Nutd21, or combinations thereof prior to or during a reprogramming procedure. Such inhibitors can improve both the speed and efficiency of cellular reprogramming. Inhibitors of the CAF-1 complex can also be used in the treatment of cancer.
申请公布号 WO2016033160(A2) 申请公布日期 2016.03.03
申请号 WO2015US46903 申请日期 2015.08.26
申请人 THE GENERAL HOSPITAL CORPORATION 发明人 HOCHEDLINGER, KONRAD
分类号 A61K48/00;C12N15/85 主分类号 A61K48/00
代理机构 代理人
主权项
地址